Synthon

About Synthon

Synthon is a leading international pharmaceutical company specializing in the development and provision of affordable, high-quality small molecule generics and hybrid drugs. The company serves a diverse range of clients, including over 200 marketing partners and the top 10 generic pharma companies worldwide. Operating in the global pharmaceutical market, Synthon focuses on delivering cost-effective medication solutions across multiple therapeutic areas. The business model is vertically integrated, meaning it controls the entire process from research and development to manufacturing and distribution. This allows Synthon to maintain high standards of scientific rigor and integrity, ensuring the quality and efficacy of its products. Revenue is generated through the sale of its extensive product portfolio, which includes over 60 different molecules. Additionally, Synthon is involved in the manufacturing of linker drugs for Antibody Drug Conjugates (ADCs) and has capabilities in oligonucleotide synthesis, catering to the growing demand in these specialized fields.